Medannex
About:
Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1.
Website: https://www.medannex.org/
Twitter/X: MedannexLtd
Top Investors: Innovate UK, Morningside Venture Investments, Scottish Investment Bank
Description:
Medannex's goal is to create a first-in-class antibody therapy to improve the lives of people impacted by cancers and autoimmune diseases.
Total Funding Amount:
11.3M GBP
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Edinburgh, Edinburgh, City of, United Kingdom
Founded Date:
2009-01-01
Founders:
Chris Wood
Number of Employees:
11-50
Last Funding Date:
2024-07-25
IPO Status:
Private
Industries:
© 2025 bioDAO.ai